qPharmetra

Executive Summary

qPharmetra is a pharmacometrics and clinical pharmacology consulting firm that leverages advanced modeling and simulation to optimize drug development decisions for biopharmaceutical clients. Founded in 2010 and based in Boulder, Colorado, the company provides quantitative analysis, strategic consulting, and custom software tools to improve clinical trial efficiency and dose selection from early-stage through regulatory submission. Operating at the intersection of drug delivery and digital health, qPharmetra helps clients accelerate timelines, reduce costs, and increase the probability of success in bringing therapies to market. Its services target a growing need for quantitative expertise as regulators increasingly endorse model-informed drug development approaches.

Upcoming Catalysts (preview)

• Q4 2026Release of next-generation pharmacometrics software platform70% success
• Q2 2026Adoption of new FDA guidance on model-informed drug development90% success
• Q3 2026Strategic partnership with a top-20 pharmaceutical company50% success